The 18th World Congress of Basic and Clinical Pharmacology (WCP2018), coordinated by IUPHAR and hosted by the Japanese Pharmacological Society and the Japanese Society of Clinical Pharmacology and Therapeutics, was held in July 2018 at the Kyoto International Conference Center, in Kyoto, Japan. Having as its main theme 'Pharmacology for the Future: Science, Drug Development and Therapeutics', WCP2018 was attended by over 4500 delegates, representing 78 countries. The present report is an overview of a symposium at WCP2018, entitled Pharmacogenomics in Special Populations, organized by IUPHAR´s Pharmacogenetics/Genomics (PGx) section. The PGx section congregates distinguished scientists from different continents, covering expertise from basic research, to clinical implementation and ethical aspects of PGx, and one of its major activities is the coordination of symposia and workshops to foster exchange of PGx knowledge (https://iuphar.org/sections-subcoms/pharmacogenetics-genomics/). The symposium attracted a large audience to listen to presentations covering various areas of research and clinical adoption of PGx in Oceania, Africa, Latin America and Asia.
OMICS. 2016 Sep;20(9):496-7
[PMID:
27631188]
Pharmacogenomics J. 2013 Dec;13(6):484-9
[PMID:
23089673]
Br J Pharmacol. 2017 Dec;174 Suppl 1:S272-S359
[PMID:
29055034]
OMICS. 2016 Sep;20(9):538-45
[PMID:
27631193]
Pharmacogenetics. 2001 Feb;11(1):69-76
[PMID:
11207032]
Pharmacogenomics. 2014 Feb;15(2):209-19
[PMID:
24444410]
OMICS. 2014 Dec;18(12):733-9
[PMID:
25454511]
PLoS One. 2014 Jan 31;9(1):e86919
[PMID:
24497997]
PLoS One. 2013 Jul 05;8(7):e67946
[PMID:
23861838]
BMJ. 2015 Sep 23;351:h4848
[PMID:
26399967]
Pharmacogenomics. 2016 Apr;17(6):603-13
[PMID:
27045425]
Br J Clin Pharmacol. 2016 Nov;82(5):1303-1307
[PMID:
27304207]
N Engl J Med. 2013 Oct 24;369(17):1620-8
[PMID:
24152261]
Cancer Chemother Pharmacol. 2014 Apr;73(4):779-88
[PMID:
24519753]
Pharmacogenet Genomics. 2007 Jul;17(7):497-504
[PMID:
17558305]
Pharmacogenet Genomics. 2017 Dec;27(12):429-437
[PMID:
28885988]
Clin Pharmacol Ther. 2008 Dec;84(6):722-8
[PMID:
18754001]
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4134-9
[PMID:
15743917]
JAMA. 2013 Mar 20;309(11):1100
[PMID:
23512037]
Pharmacogenomics. 2017 Jun;18(9):891-910
[PMID:
28594321]
Pharmacogenomics J. 2012 Dec;12(6):499-506
[PMID:
21862974]
Pharmacogenet Genomics. 2006 Apr;16(4):297-306
[PMID:
16538176]
Annu Rev Genomics Hum Genet. 2008;9:403-33
[PMID:
18593304]
Front Pharmacol. 2012 Nov 06;3:191
[PMID:
23133420]
Malar J. 2018 Feb 01;17(1):57
[PMID:
29390987]
J Clin Pharm Ther. 2018 Aug;43(4):493-499
[PMID:
29682780]
PLoS One. 2011 Feb 16;6(2):e17063
[PMID:
21359226]
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
[PMID:
29149325]
Pharmacogenet Genomics. 2018 Jun;28(6):153-164
[PMID:
29768302]
Pharmacogenomics. 2008 Oct;9(10):1445-58
[PMID:
18855533]
PLoS One. 2012;7(7):e40180
[PMID:
22808112]
J Dermatol. 2016 Jul;43(7):758-66
[PMID:
27154258]
Clin Pharmacol Ther. 2015 Jul;98(1):19-24
[PMID:
25801146]
Pharmacogenomics. 2015;16(10):1047-64
[PMID:
25831219]
J Pharmacol Exp Ther. 1996 Jul;278(1):441-6
[PMID:
8764380]
J Clin Oncol. 2015 Apr 10;33(11):1235-42
[PMID:
25624441]
PLoS One. 2014 Apr 08;9(4):e94271
[PMID:
24714066]
Pharmacogenomics J. 2016 Feb;16(1):88-95
[PMID:
25963334]
PLoS Genet. 2012;8(3):e1002554
[PMID:
22412386]
Pharmacogenetics. 1993 Oct;3(5):264-9
[PMID:
8287065]
Malar J. 2017 Jul 3;16(1):267
[PMID:
28673292]
Clin Pharmacol Ther. 2017 Sep;102(3):397-404
[PMID:
28198005]
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8611-6
[PMID:
19433783]
Pharmacogenet Genomics. 2013 Aug;23(8):415-27
[PMID:
23778320]
Pharmacogenomics. 2011 Sep;12(9):1293-303
[PMID:
21806386]
Brain Res Bull. 1997;44(5):561-71
[PMID:
9365799]
JAMA. 2012 Jul 25;308(4):387-402
[PMID:
22820792]
Int J Clin Pharmacol Ther. 2014 Jun;52(6):446-53
[PMID:
24755134]
Eur J Clin Pharmacol. 2008 Apr;64(4):357-65
[PMID:
18057928]
BMC Genomics. 2016 Sep 26;17(1):755
[PMID:
27671213]
Eur J Clin Pharmacol. 2012 May;68(5):689-95
[PMID:
22108776]
Clin Pharmacol Ther. 2011 Oct;90(4):625-9
[PMID:
21900891]
BMC Infect Dis. 2013 Jun 04;13:261
[PMID:
23734829]
N Engl J Med. 2011 Mar 24;364(12):1126-33
[PMID:
21428768]
Antivir Ther. 2009;14(5):687-95
[PMID:
19704172]
Nat Genet. 2016 Apr;48(4):367-73
[PMID:
26878724]
JAMA. 2014 Aug 6;312(5):525-34
[PMID:
25096692]
Br J Clin Pharmacol. 1996 Dec;42(6):713-9
[PMID:
8971426]
OMICS. 2017 Mar;21(3):123-131
[PMID:
28253087]
Drug Metab Pharmacokinet. 2012;27(1):9-54
[PMID:
22123129]
Eur J Clin Pharmacol. 2018 Nov;74(11):1405-1415
[PMID:
30003275]
Clin Pharmacol Ther. 2008 Sep;84(3):326-31
[PMID:
18305455]
Public Health Genomics. 2015;18(1):40-51
[PMID:
25427668]
Blood. 2009 Apr 23;113(17):4125-6
[PMID:
19389892]
Int J Clin Pharmacol Ther. 2011 Feb;49(2):162-8
[PMID:
21255533]
Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):55-68
[PMID:
19968575]
Pharmacogenet Genomics. 2016 May;26(5):225-34
[PMID:
26928377]
Clin Pharmacol Ther. 2019 Jan;105(1):112-120
[PMID:
29569740]
Front Pharmacol. 2017 Feb 27;8:90
[PMID:
28289388]
Malar J. 2015 Apr 25;14:179
[PMID:
25906774]
Clin Infect Dis. 2013 May;56(9):1330-9
[PMID:
23362284]
HIV Med. 2011 Oct;12(9):517-24
[PMID:
21951595]
PLoS One. 2014 Nov 24;9(11):e112640
[PMID:
25419701]
JAMA Neurol. 2018 Jul 1;75(7):842-849
[PMID:
29610831]
Br J Clin Pharmacol. 2019 Mar;85(3):467-475
[PMID:
30537134]
Glob Health Action. 2018;11(1):1419033
[PMID:
29336236]
Clin Pharmacokinet. 2002;41(9):681-90
[PMID:
12126459]
